Fig. 1.
(A–C) Ratio to baseline at day 85 and (D) including visits up to day 85a
(A–C) Posterior medians are based on a Bayesian analysis at day 85 only. (D) Posterior medians are based on a Bayesian longitudinal analysis. aPer protocol population. αSMA: alpha smooth muscle actin; CCL2: C-C motif chemokine ligand 2; PIIINP: procollagen type III N-terminal peptide;
2GSSC: 2-gene skin score; BL: baseline; CrI: credible interval.